Is absolute quantification of dopaminergic neurotransmission studies with 123I SPECT ready for clinical use?

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 7, 2008, Pages 1330-1333

  Zaidi, Habib ^a   El Fakhri, Georges ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; COCAINE DERIVATIVE; DOPAMINE TRANSPORTER; IODINE 123; NEUROLIGAND; RADIOLIGAND;

CAUDATE NUCLEUS; COMPUTER PROGRAM; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOPAMINERGIC ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; HUNTINGTON CHOREA; MOTOR DYSFUNCTION; NEUROTRANSMISSION; NOTE; PARKINSON DISEASE; PROGRESSIVE SUPRANUCLEAR PALSY; PUTAMEN; QUANTITATIVE ASSAY; SHY DRAGER SYNDROME; SIMULATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WILSON DISEASE;

BRAIN; CAUDATE NUCLEUS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; IODINE RADIOISOTOPES; LIGANDS; MOVEMENT DISORDERS; PUTAMEN; RADIOPHARMACEUTICALS; SYNAPTIC TRANSMISSION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 45049086166     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-0842-x     Document Type: Note

References (35)

1. Laruelle M, Baldwin RM, Malison RT, Zea-Ponce Y, Zoghbi SS, al-Tikriti MS, et al. SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates. Synapse 1993;13:295-309.
2. Fischman AJ, Bonab AA, Babich JW, Palmer EP, Alpert NM, Elmaleh DR, et al. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters. Synapse 1998;29:128-41.
3. Abi-Dargham A, Gandelman MS, DeErausquin GA, Zea-Ponce Y, Zoghbi SS, Baldwin RM, et al. SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT. J Nucl Med 1996;37:1129-33.
4. Schwarz J, Antonini A, Tatsch K, Kirsch CM, Oertel WH, Leenders KL. Comparison of 123I-IBZM SPECT and 11C-raclopride PET findings in patients with parkinsonism. Nucl Med Commun 1994;15:806-13.
5. Ichise M, Ballinger JR, Golan H, Vines D, Luong A, Tsai S, et al. Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT. J Nucl Med 1996;37:513-20.
6. Madsen MT. Recent advances in SPECT imaging. J Nucl Med 2007;48:661-73.
7. Wagenaar DJ, Kapusta M, Li J, Patt BE. Rationale for the combination of nuclear medicine with magnetic resonance for pre-clinical imaging. Technol Cancer Res Treat 2006;5:343-50.
8. Crespo C, Gallego J, Cot A, Falcón C, Bullich S, Pareto D, et al. Quantification of dopaminergic neurotransmission SPECT studies with (123)I-labelled radioligands. A comparison between different imaging systems and data acquisition protocols using Monte Carlo simulation. Eur J Nucl Med Mol Imaging. 2008;in press. DOI 10.1007/s00259-007-0711-z.
9. Zaidi H, Montandon M-L, Meikle S. Strategies for attenuation compensation in neurological PET studies. Neuroimage 2007;34:518-41.
10. El Fakhri G, Kijewski MF, Albert MS, Johnson KA, Moore SC. Quantitative SPECT leads to improved performance in discrimination tasks related to prodromal Alzheimer's disease. J Nucl Med 2004;45:2026-31.
11. Zaidi H, Koral KF. Scatter modelling and compensation in emission tomography. Eur J Nucl Med Mol Imaging 2004;31:761-82.
12. Koch W, Mustafa M, Zach C, Tatsch K. Influence of movement on FP-CIT SPECT quantification: a Monte Carlo based simulation. Nucl Med Commun 2007;28:603-14.
13. Shao L, Billings J, Pfeiffer N, Kung HF. Concentration recovery for SPECT CNS dopamine-receptor studies for monkeys. Med Phys 1994;21:675-81.
14. 123I SPECT. J Nucl Med 2003;44:1184-93.
15. Cherry S, Sorenson JA, Phelps ME. Physics in nuclear medicine. 3rd ed. Philadelphia: Saunders; 2004.
16. Rowe RK, Aarsvold JN, Barrett HH, Chen JC, Klein WP, Moore BA, et al. A stationary hemispherical SPECT imager for three-dimensional brain imaging. J Nucl Med 1993;34:474-80.
17. Genna S, Smith AP. The development of ASPECT, an annular single crystal brain camera for high efficiency SPECT. IEEE Trans Nucl Sci 1988;35:654-8.
18. El Fakhri G, Ouyang J, Zimmerman RE, Fischman AJ, Kijewski MF. Performance of a novel collimator for high-sensitivity brain SPECT. Med Phys 2006;33:209-15.
19. Rogers WL, Clinthorne NH, Shao L, Chiao P, Ding Y, Stamos JA, et al. SPRINT II: a second generation single photon ring tomograph. IEEE Trans Med Imaging 1988;7:291-7.
20. Farncombe T, Celler A, Noll D, Maight J, Harrop R. Dynamic SPECT imaging using a single camera rotation (dSPECT). IEEE Trans Nucl Sci 1999;46:1055-61.
21. Wong WH, Li H, Uribe J, Baghaei H, Wang Y, Yokoyama S. Feasibility of a high-speed gamma-camera design using the high-yield-pileup-event-recovery method. J Nucl Med 2001;42:624-32.
22. Ljungberg M, Strand S-E, King MA. Monte Carlo calculations in nuclear medicine: applications in diagnostic imaging. Bristol: IOP Publishing; 1998.
23. Zaidi H. Relevance of accurate Monte Carlo modeling in nuclear medical imaging. Med Phys 1999;26:574-608.
24. Dewaraja YK, Ljungberg M, Koral KF. Monte Carlo evaluation of object shape effects in iodine-131 SPET tumor activity quantification. Eur J Nucl Med 2001;28:900-6.
25. Floyd CE, Jaszczak RJ, Greer KL, Coleman RE. Inverse Monte Carlo as a unified reconstruction algorithm for ECT. J Nucl Med 1986;27:1577-85.
26. Beekman FJ, de Jong HW, van Geloven S. Efficient fully 3-D iterative SPECT reconstruction with Monte Carlo-based scatter compensation. IEEE Trans Med Imag 2002;21:867-77.
27. Ouyang J, Fakhri GE, Moore SC. Fast Monte Carlo based joint iterative reconstruction for simultaneous [sup 99m]Tc/[sup 123]I SPECT imaging. Med Phys 2007;34:3263-72.
28. Wilson DW, Tsui BMW, Barrett HH. Noise properties of the EM algorithm. II. Monte Carlo simulations. Phys Med Biol 1994;39:847-71.
29. Zaidi H, Xu XG. Computational anthropomorphic models of the human anatomy: the path to realistic Monte Carlo modeling in medical imaging. Annu Rev Biomed Eng 2007;9:471-500.
30. Koch W, Hamann C, Radau PE, Tatsch K. Does combined imaging of the pre- and postsynaptic dopaminergic system increase the diagnostic accuracy in the differential diagnosis of parkinsonism? Eur J Nucl Med Mol Imaging 2007;34:1265-73.
31. Tossici-Bolt L, Hoffmann SMA, Kemp PM, Mehta RL, Fleming JS. Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio. Eur J Nuc Med Mol Imaging 2006;33:1491-9.
32. El Fakhri G, Moore SC, Maksud P, Aurengo A, Kijewski MF. Absolute activity quantitation in simultaneous 123I/99mTc brain SPECT. J Nucl Med 2001;42:300-8.
33. Du Y, Tsui BMW, Frey EC. Model-based compensation for quantitative 123I brain SPECT imaging. Phys Med Biol 2006;51:1269-82.
34. Vanzi E, De Cristofaro M, Ramat S, Sotgia B, Mascalchi M, Formiconi A. A direct ROI quantification method for inherent PVE correction: accuracy assessment in striatal SPECT measurements. Eur J Nuc Med Mol Imaging 2007;34:1480-9.
35. Koch W, Radau PE, Hamann C, Tatsch K. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. J Nucl Med 2005;46:1109-18.